SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany
· Delayed Price · Currency is EUR 23.00
+0.10 (0.44%)
Last updated: Aug 14, 2025
SCHOTT Pharma AG & Co. KGaA Employees
As of September 30, 2024, SCHOTT Pharma AG & Co. KGaA had 4,690 total employees, including 4,517 full-time and 173 part-time employees. The number of employees increased by 44 or 0.95% compared to the previous year.
Employees
4,690
Change (1Y)
44
Growth (1Y)
0.95%
Revenue / Employee
€204,330
Profits / Employee
€30,759
Market Cap
3.45B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 4,690 | 44 | 0.95% |
| Sep 30, 2023 | 4,646 | -37 | -0.79% |
| Sep 30, 2022 | 4,683 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Bayer Aktiengesellschaft | 91,864 |
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Sartorius Aktiengesellschaft | 13,528 |
| Fielmann Group AG | 24,363 |
| Carl Zeiss Meditec AG | 5,730 |
SCHOTT Pharma AG & Co. KGaA News
- 2 days ago - SCHOTT Pharma's Q3 Success: Strong Results Delivered! - Wallstreet:Online
- 2 days ago - EQS-News: SCHOTT Pharma delivers solid final third-quarter results - Wallstreet:Online
- 9 days ago - SCHOTT Pharma Unveils Q3 2025 Results & FY Guidance - Wallstreet:Online
- 9 days ago - EQS-News: SCHOTT Pharma reports preliminary results for Q3 2025 and specifies FY 2025 guidance - Wallstreet:Online
- 9 days ago - SCHOTT Pharma Targets 2025 Revenue & EBITDA Growth - Wallstreet:Online
- 9 days ago - EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma specifies FY 2025 guidance for revenue growth and EBITDA margin - Wallstreet:Online
- 2 months ago - EQS-News: SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appoints Reinhard Mayer as new CFO - Wallstreet:Online
- 3 months ago - CTP builds 18,000 sqm Serbian facility for SCHOTT Pharma as it expands global manufacturing network - Wallstreet:Online